Real-World Data Analysis Reveals a Lower Risk of Tardive

Presented as a Poster of Distinction at Digestive Disease Week (DDW) 2022, showed a 98.8 per 100,000 (0.1%) incidence of TD among gastroparesis patients...

Related Keywords

El Paso ,Texas ,United States ,San Diego ,California ,Solana Beach ,American ,Richard Mccallum ,Daniel Kontoh Boateng ,Texas Tech University Health Science Center ,American Society For Gastrointestinal Endoscopy ,Linkedin ,Society For Surgery Of The Alimentary Tract ,Nasdaq ,Exchange Commission ,Truven Health Marketscan Commercial Database ,Facebook ,Pharma Inc ,Department Of Medicine ,American Gastroenterological Association ,Digestive Disease Week ,Safety Profile ,Only Approved Molecule ,Treat Symptoms ,Recurrent Diabetic Gastroparesis ,Digestive Disease ,Tardive Dyskinesia ,Metoclopramide Use ,Real World Data Driven Epidemiology Study ,Founding Chair ,Truven Health Marketscan Commercial ,American Association ,Liver Diseases ,American Society ,Gastrointestinal Endoscopy ,Alimentary Tract ,Evoke Pharma ,Private Securities Litigation Reform Act ,Nasdaq Evok ,Nc ,Davok ,Evoke ,Timoti ,